THP-1 l

Cat.No.: CSC-6320W

Species: Homo sapiens (Human)

Source: Blood; Peripheral Blood

Morphology: continuous culture, grown in suspension, morphology large, round, single cells

Culture Properties: suspension

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-6320W
Description
Species: human;
Tissue: peripheral blood;
Tumor: leukemia, acute monocytic;
Derived from: THP-1
Species
Homo sapiens (Human)
Source
Blood; Peripheral Blood
Recommended Medium
Culture Properties
suspension
Morphology
continuous culture, grown in suspension, morphology large, round, single cells
STR DNA Profile
Amelogenin: X,Y;
vWA: 16;
FGA: 24,25;
TH01: 8,9.3;
D18S51: 13,14;
D21S11: 30,31.2;
D8S1179: 10,14
Disease
Acute Monocytic Leukemia
Quality Control
Sterility: mycoplasma negative, HOECHST and PCR
Storage and Shipping
Frozen with 90% FBS + 10% DMSO; ship in dry ice; store in liquid nitrogen
Synonyms
THP-1l
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

The THP-1 cell line remains the global gold standard for modeling human monocytic and macrophage biology. Our enhanced THP-1 (THP-1-l) variant is specifically curated through strict lineage maintenance and low-passage expansion, ensuring the retention of robust phagocytic capacity, migratory responsiveness, and sensitivity to pro-inflammatory stimuli-features often lost in standard laboratory-maintained stocks.

  • Optimized Differentiation Fidelity: THP-1-l exhibits superior sensitivity to PMA-induced differentiation, rapidly transitioning into a functional macrophage-like state. This cell line consistently generates homogeneous populations, which is essential for studying M1/M2 polarization and phenotypic plasticity.
  • Predictable Inflammasome Kinetics: Characterized by high-fidelity activation of the NLRP3 inflammasome, this line provides a highly reliable platform for assessing cytokine release (e.g., IL-1β, TNF-α) and testing the inhibitory efficacy of novel anti-inflammatory compounds.
  • Genetic Stability & Transduction Efficiency: By limiting passage numbers, we ensure higher structural integrity of the genome and reliable expression of cell surface markers (e.g., CD14, CD11b). This makes our THP-1-l the ideal substrate for CRISPR/Cas9 editing and lentiviral transduction to study host-pathogen interactions.
  • High-Throughput Screening (HTS) Consistency: With consistent growth kinetics and standardized doubling times, our THP-1-l minimizes experimental variance, allowing for reproducible data collection across multi-well platforms for drug discovery and toxicity screening.

By choosing our low-passage THP-1-l, you invest in a highly validated, stable, and functionally superior model that brings unparalleled accuracy to your inflammatory and immunological research.

Platelet-Derived Microvesicles Modulate Cytokine and Lipid Mediator Profiles in THP-1 Monocytes

Monocytes are circulating immune cells that migrate to inflamed tissues and differentiate into macrophages, where they play a dual role in regulating pro-inflammatory and pro-resolving responses through cytokine and lipid mediator secretion. Platelet-derived microvesicles (PMVs), released during platelet activation, infiltrate inflamed areas and interact with monocytes and macrophages, facilitating the transfer of bioactive contents. While these interactions have been observed, their functional consequences on monocyte/macrophage inflammatory profiles remain poorly understood.

In this study, PMVs are shown to be internalized by human THP-1 monocytes. The interaction with THP-1 cells occurs rapidly, with 60 % of cells interacting with PMVs within one hour. When cells are differentiated to M0 and M1 macrophages, interactions with PMVs only peak after 24 h. Interaction of cells with PMVs resulted in an increased capacity to synthesize cyclooxygenase- and lipoxygenase-derived lipid mediators of inflammation, especially in M1 cells. Cytokine production was also influenced in a cell-state-dependent manner. PMVs had no impact on undifferentiated THP-1 cells but enhanced the production of several cytokines in M0 cells as well as IL-23 and IL-6 in M1 macrophages. When stimulated with lipopolysaccharides, PMV-treated M0 macrophages demonstrated elevated production of the anti-inflammatory cytokine IL-10, while M1 macrophages exhibited increased secretion of IL-1β, MCP-1, and IL-6, highlighting an effect on pro-inflammatory cytokine production. These findings reveal that PMVs selectively modulate the inflammatory cytokine and lipid mediator profiles of monocytes and macrophages depending on their differentiation state.

Confocal microscopy analysis of the colocalization of PMVs and THP-1 cells.

Fig. 1. Confocal microscopy images of THP-1 cells incubated with PKH67-labeled PMVs (Foulem, Robert D., et al., 2025).

Lipid mediator profiles of THP-1, M0, and M1 cells following incubation with PMVs.

Fig. 2. Lipid mediator profile in stimulated THP-1, M0 and M1 cells following incubation with PMVs (Foulem, Robert D., et al., 2025).

Ask a Question

Write your own review

  • You May Also Need

For research use only. Not for any other purpose.

Hot Products